Repository logo

Acronym
Librexia-Stroke
Project Title
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
Principal Investigator
Start Date
January 27, 2023
Project Web Site
Keywords
Stroke
Project Type
Interventional/Clinical trials research
Location
Region
Keywords

Stroke

Description
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

NT Health Library Services acknowledges the Traditional Custodians of Country throughout the Northern Territory and recognises their continuing cultural and spiritual connections to the lands, waters, and communities. We pay our respects to elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander people across the Northern Territory and beyond, many of whom are represented in our collections.

© 2025 Northern Territory Government of Australia